← Leaderboards
Lukasz Michal Ciesla
Regis Technologies Inc
$325,202
Attributed
$399,702
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $223.9K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$399,702 · 2
By mechanism
R41$250,702 · 1
R03$149,000 · 1
Top collaborators
- Urmila Maitra2 shared
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsPhytochemicalPlant ExtractsNeurodegenerative DisordersBaseLeadBiologicalNational Center For Complementary And Integrative HealthBindingAlzheimer&AposAdoptionAffinity ChromatographyAge-Associated Memory ImpairmentAntibodiesBiochemicalAlabamaAttenuatedAgingAffectAutomobile DrivingAyurvedic MedicineAsianBehaviorArtificial Membranes
Grant awards (4)
Centella asiatica effects on neuroinflammatory responses in Drosophila models of acute inflammation and aging$74,500
R03 · FY2023 · AT · contact PI
Centella asiatica effects on neuroinflammatory responses in Drosophila models of acute inflammation and aging$74,500
R03 · FY2022 · AT · contact PI
Cellular membrane affinity chromatography kit for drug discovery$26,807
R41 · FY2022 · AT · contact PI
Cellular membrane affinity chromatography kit for drug discovery$223,895
R41 · FY2021 · AT · contact PI